Citi’s Levkovich on AbbVie Buying Allergan for $63 Billion

Jun.25 — AbbVie Inc. has agreed to pay $63 billion for rival drugmaker Allergan Plc. Tobias Levkovich, chief U.S. equity strategist at Citi, discusses on “Bloomberg Surveillance.”